Technology
e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Where the Money Is: Healthcare Technology

Scott Mace, for HealthLeaders Media, October 9, 2012

Win or lose, Obamacare has unleashed private business to solve the healthcare problem. Central planning isn't ruling the day: witness the ONC's recent decision to put off governing the nationwide health information network. Everywhere government chooses not to go in healthcare, private money appears ready to rush in.

Just look at this past week's deals. The Qualcomm Foundation awards $3.75 million to Scripps Health to develop wireless biosensor systems to help detect and treat heart attacks, type 1 diabetes, and certain types of cancer.

But that was dwarfed by the $100 million UPMC pledged to spend in the next five years on a personalized medicine data warehouse.

"Our intention is to add to our existing investment in electronic health records and financial information systems, with additional investments to support data models and technologies, appliances, tools, applications to really unlock the power of our digital information, and to really be able to study and understand and answer questions related to patient care, patient outcomes, quality, quality metrics, care delivery, and especially science," explains Lisa Khorey, vice president of enterprise systems and data management at UPMC.

1 | 2 | 3 | 4

Comments are moderated. Please be patient.

1 comments on "Where the Money Is: Healthcare Technology"


jkuriyan (10/9/2012 at 3:16 PM)
There are plenty of data warehouses in healthcare - most of them trying to catch "outliers". If I'm to use an analogy with accounting, we in healthcare are using "general ledgers" capturing all the transactions - and spotting the highest, lowest etc. We need to get to the next phase. In accounting it was the use of business ratios and similar ones in economics too. There is a huge amount of information buried in all these warehouses - but they are accessible only to a small group of people, most of them without the modern mathematical skills to get to the next stage. I wish they would set aside 10% of the funds in trying to revisit the data they already have - and develop some interesting new models, as economists have.